Heidelberg Pharma AG

Director's Dealing • Jul 6, 2017

News Details

Directors’ Dealings | 6 July 2017 11:43

DGAP-DD: WILEX AG english

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

06.07.2017 / 11:43

The issuer is solely responsible for the content of this announcement.

---

1. Details of the person discharging managerial responsibilities / person closely associated

a) Name

Name and legal form:	dievini Hopp BioTech holding GmbH & Co. KG

2. Reason for the notification

a) Position / status

Person closely associated with:
Title:
First name:	–
Last name(s):	C. Hettich / F. von Bohlen und Halbach / M. Hothum
Position:	Member of the administrative or supervisory body

b) Amendment

Correction of a release of 18 May 2017, 10:06 am; change of date of the transaction

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name

WILEX AG

b) LEI

391200E09XYBYITR1W32

4. Details of the transaction(s)

a) Description of the financial instrument, type of instrument, identification code

Type:	Share
ISIN:	DE000A2E4SX4

b) Nature of the transaction

Purchase by subscription rights

c) Price(s) and volume(s)

Price(s)	Volume(s)
2.45 EUR	2748738.30 EUR

d) Aggregated information

Price	Aggregated volume
2.45 EUR	2748738.30 EUR

e) Date of the transaction

2017-05-15; UTC+2

f) Place of the transaction

Outside a trading venue

---

06.07.2017 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

Archive at www.dgap.de

---

Language:	English
Company:	WILEX AG
	Grillparzerstr. 18
	81675 München
	Germany
Internet:	www.wilex.com

End of News	DGAP News Service